How to lower creatinine with food, and what really works
Updated: 4 hours ago
The short answer
You can lower the creatinine number on a lab report with food, but that is not the same as helping your kidneys. Skipping meat, avoiding creatine, and being well hydrated before a blood draw all lower measured creatinine for a day without changing your actual kidney function. What genuinely protects kidneys over time is cutting phosphate additives and sodium, eating a plant-based Mediterranean-style pattern, and, when you qualify, taking medicines with real trial evidence such as SGLT2 inhibitors. Watch the trend across months, not a single reading.
What we cover
Why creatinine reflects both muscle mass and kidney filtering, so the number alone can mislead you
How a single cooked meat meal raises serum creatinine for about 12 hours (Diabetes Care, 2014)
Why detox teas and forcing water do not protect kidneys (CKD WIT trial, JAMA, 2018)
Which foods actually matter: phosphate additives absorbed at over 90 percent versus 20 to 40 percent from plants (CJASN, 2010)
Why a plant-based, Mediterranean-style eating pattern fits the KDIGO 2024 kidney guideline
The two drug classes with trial evidence to slow kidney decline: SGLT2 inhibitors (EMPA-KIDNEY, NEJM, 2023) and the GLP-1 semaglutide
When creatinine and cystatin C estimates disagree, and why the combined estimate lands closest (NEJM, 2021)
Timestamps
0:00 A lower number versus healthier kidneys
0:45 What creatinine reflects
1:23 Cooked meat, creatine and lab changes
3:06 Cystatin C and testing conditions
4:28 Detox claims and the water trial
6:52 Phosphate additives, sodium and diet
8:41 Protein: healthy kidneys versus CKD
9:51 Medicines with kidney outcome evidence
12:10 Trends and disagreeing kidney estimates
14:31 Build a baseline with your care team
References
Nair S, O'Brien SV, Hayden K, Pandya B, Lisboa PJG, Hardy KJ, Wilding JPH. Effect of a cooked meat meal on serum creatinine and estimated glomerular filtration rate in diabetes-related kidney disease. Diabetes Care. 2014;37(2):483-487. doi:10.2337/dc13-1770 https://doi.org/10.2337/dc13-1770
Cooked meat and creatinine. A controlled feeding study where a cooked meat meal raised serum creatinine and lowered eGFR across CKD stages, clearing after 12 hours of fasting. Diabetes Care, 2014. Interventional crossover study. doi:10.2337/dc13-1770 https://doi.org/10.2337/dc13-1770
Clark WF, et al. Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: the CKD WIT randomized clinical trial. JAMA. 2018;319(18):1870-1879. doi:10.1001/jama.2018.4930 https://doi.org/10.1001/jama.2018.4930
Water intake and kidney decline. The CKD WIT randomized trial found that coaching adults with CKD to drink more water for a year did not slow kidney function decline. JAMA, 2018. Randomized trial. doi:10.1001/jama.2018.4930 https://doi.org/10.1001/jama.2018.4930
Kalantar-Zadeh K, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3):519-530. doi:10.2215/CJN.06080809 https://doi.org/10.2215/CJN.06080809
Dietary phosphorus sources. A review explaining that inorganic phosphate additives are absorbed at over 90 percent versus 20 to 40 percent for natural plant phosphorus. Clinical Journal of the American Society of Nephrology, 2010. Review. doi:10.2215/CJN.06080809 https://doi.org/10.2215/CJN.06080809
EMPA-KIDNEY Collaborative Group; Herrington WG, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127. doi:10.1056/NEJMoa2204233 https://doi.org/10.1056/NEJMoa2204233
Empagliflozin in CKD. EMPA-KIDNEY slowed kidney disease progression, including in people without diabetes. New England Journal of Medicine, 2023. Randomized trial. doi:10.1056/NEJMoa2204233 https://doi.org/10.1056/NEJMoa2204233
Heerspink HJL, et al. Dapagliflozin in patients with chronic kidney disease (DAPA-CKD). N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa2024816 https://doi.org/10.1056/NEJMoa2024816
Dapagliflozin in CKD. DAPA-CKD reduced kidney disease progression and kidney failure. New England Journal of Medicine, 2020. Randomized trial. doi:10.1056/NEJMoa2024816 https://doi.org/10.1056/NEJMoa2024816
Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (FLOW). N Engl J Med. 2024;391(2):109-121. doi:10.1056/NEJMoa2403347 https://doi.org/10.1056/NEJMoa2403347
Semaglutide in CKD. FLOW cut major kidney events by 24 percent in people with type 2 diabetes and CKD. New England Journal of Medicine, 2024. Randomized trial. doi:10.1056/NEJMoa2403347 https://doi.org/10.1056/NEJMoa2403347
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
KDIGO 2024 CKD guideline. Supports a plant-based, Mediterranean-style pattern and does not tell healthy people to slash protein. Kidney International, 2024. Clinical practice guideline. KDIGO 2024 guideline https://kdigo.org/guidelines/ckd-evaluation-and-management/
Inker LA, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953 (NKF-ASN Task Force: Delgado C, et al. 2021.) https://doi.org/10.1056/NEJMoa2102953
Creatinine and cystatin C equations. The 2021 race-free equations show the combined creatinine-plus-cystatin C estimate is more accurate than either alone. New England Journal of Medicine, 2021. Equation development and validation study. doi:10.1056/NEJMoa2102953 https://doi.org/10.1056/NEJMoa2102953
One study explained in plain language every week, with sources attached, plus the free kidney health guide: https://guides.selfprinciple.org/kidney
This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for individual care. The views expressed are Dr. Sean Hashmi's own and do not represent his employer.
Comments